Clinical Trial Update: NET-PD LS-1 Creatine in Parkinson's Disease [Phase 3]

View source ↗

Summary

A Phase 3 trial of creatine (NET-PD LS-1) in Parkinson's disease was terminated, with results posted in 2015.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Creatine (creatine)

Snippet

Sponsor: University of Rochester | Conditions: Parkinson's Disease | Phase 3 | Status: TERMINATED | Results posted: 2015-04-02